April 2nd 2025
Epax has announced the launch of what they say is the first commercially available very long chain polyunsaturated fatty acid (VLC-PUFA), called Epax Evolve 05.
CPC Ingredients - Feeding Beauty Trends
October 6th 2009In May, Datamonitor reported that growth of the nutricosmetics market may be slowing, perhaps due to the recession. Some consumers, the report said, may view beauty-from-within products as a luxury. While new beauty beverages continue to launch, other types of nutricosmetics may not fare as well, said Datamonitor, citing the failure of Danone's Essensis skin-nourishing yogurt as an example.
XSTO Solutions Announces U.S. Distribution of BRUDY’S New DHA
May 6th 2009XSTO Solutions (Morristown, NJ) and Brudy Technology (Barcelona, Spain) have jointly announced a new sales and marketing distribution agreement between the two companies to market Algatrium, Brudy’s patented source of DHA.
Omega Fatty Acids Gaining Prominence in Global Market
January 22nd 2009In a new report, "Omega Fatty Acids: Trends in the Worldwide Food and Beverage Markets, 2nd Edition," market research publisher Packaged Facts estimates that the omega fatty acid global market grew 36% between 2007 and 2008.
Martek Reaches 100 DHA Products
November 19th 2008Martek Biosciences Corp. (Columbia, MD) announced the launch of two new products containing \"life\'sDHA,\" a polyunsaturated omega-3 fatty acid found in the body. The company subsequently reached 100 products containg DHA, Martek announced on November 18. “A growing number of experts around the world are recognizing the importance of DHA for healthy brains, eyes and hearts. They are also recognizing that most people\'s diets do not include adequate amounts of DHA,\" said Steve Dubin, Martek\'s CEO.
NIH-Supported Researchers Launch Nationwide Omega-3 Trial
May 19th 2008Researchers supported by the National Institute on Aging (NIA), part of the National Institutes of Health (Bethesda, MD), will conduct a nationwide clinical trial to invesigate whether omega-3 fatty acids slow Alzeimer's disease.
FDA Encouraged to Review EPA and DHA Omega-3 Science
May 19th 2008In response to the US Food and Drug Administration’s (FDA) notice of proposed rulemaking prohibiting nutrient content claims on products with EPA and DHA omega-3 fatty acids, the Global Organization for EPA and DHA Omega-3s (GOED; Salt Lake City) has urged the FDA and/or the Institute of Medicine to review the clinical science on omega-3s and make an authoritative statement on a recommended intake for EPA and DHA.